Feb 17, 2021
EpiVax Announces Participation in International Consortium for Development of Next-Generation Influenza Vaccines (INDIGO)
Dec 31, 2020
EpiVax and EpiVax Therapeutics Advance COVID-19 Vaccine Program, EPV-CoV-19
Dec 29, 2020
EpiVax Advances "PANDA" Peptide Therapeutic Immunogenicity Screening Program
Oct 22, 2020
FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation of New Immunoinformatic Tool for Prospective Immunogenicity Assessment of Peptide Drugs and Their Impurities
Apr 07, 2020
EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 Vaccine License Free to Developing Countries
Dec 23, 2019
EpiVax Announces Record Year for Growth in 2019 and Sets New Milestones for 2020
Dec 20, 2019
On Eve of New Decade, EpiVax Re-Pledges Commitment to Improving Health Everywhere
Nov 06, 2019
EpiVax Announces Publication of Antigen-Specific Tolerance Induction by Tregitope in Nature Scientific Reports
Oct 22, 2019
Chugai Renews License to EpiVax's ISPRI In Silico Toolkit for Immunogenicity Assessment
Mar 25, 2019
EpiVax Oncology To Present Latest Research On The Importance Of Identifying And Removing, Using Machine-Learning Based Advanced Computational Tools, Inhibitory Neoantigens From Therapeutic Cancer Vaccines, At AACR Annual Meeting 2019
Nov 01, 2018
"Bridging the Gap" Program Reduces Emergency Department Use, Reduces Health Costs and Improves Health Metrics for Uninsured Residents of Rhode Island
Oct 02, 2018
Office of Generic Drugs (OGD/FDA) Awards $1M FDA Contract to CUBRC and EpiVax for Demonstration and Validation of Immunogenicity Risk Assessment Methods for Generic Peptide Drugs and Their Impurities
Jun 12, 2018
EpiVax Oncology Completes a $1.2M Bridge Financing
May 18, 2018
$325K NIH Grant to EpiVax to Enable Development of Personalized Immunogenicity Assessment Tool for Enzyme Replacement Therapy in Pompe Disease
Mar 08, 2018
EpiVax and GAIA Vaccine Foundation Celebrate Women's Achievements Throughout History and Across Nations
Dec 19, 2017
EpiVax Announces NIH-Funded Grant To Develop New Graves' Disease Therapy
Sep 25, 2017
EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology
Sep 18, 2017
$5.8 Million Awarded For Vaccine Engineering Will Use "Immune History" To Protect Against Bird Flu, A Collaboration Led By EpiVax
Aug 03, 2017
EpiVax Awarded "Innovation Voucher" to Accelerate the Development of a Game Changing Cancer Therapy